Fiel, Milky Jane .

HRN: 12-73-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/29/2025
06/04/2025
IV
600 Mg
Q8
Cellulitis
Waiting Final Action 
05/30/2025
CEFTRIAXONE 1G (VIAL)
05/30/2025
06/06/2025
IV
2g
OD
Cap MR
Waiting Final Action 
05/30/2025
AZITHROMYCIN 500MG TABLET (TAB)
05/30/2025
06/03/2025
PO
500mg
OD
CAPMR
Waiting Final Action 
06/04/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/04/2025
06/11/2025
IV
4.5G
Q6HRS
KLEBSIELLA PNEUMONIAE INFECTION
Waiting Final Action 
06/04/2025
LEVOFLOXACIN 500MG (TAB)
06/04/2025
06/11/2025
PO
500 MG/TAB
OD
KLEBSIELLA PNEUMONIAE INFECTION
Waiting Final Action 
06/05/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/05/2025
06/09/2025
IV
500mg
OD
Klebsiella Pneumoniae Infection
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: